CHEK1 and head and neck squamous cell carcinoma: Subsequent studies using the CHK1 inhibitor PF0477736 demonstrated increased radiosensitisation in two out of three HPV-negative HNSCC cell lines associated with loss of distal chromosome 11q[64], and only one out of two HPV-negative HNSCC cell lines[65].